PM
Parametrica Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7K | Hold |
18,472
| – | – | 0.04% | 26 |
|
|
2025
Q1 | $14.6K | Hold |
18,472
| – | – | 0.02% | 22 |
|
|
2024
Q4 | $30.5K | Hold |
18,472
| – | – | 0.04% | 64 |
|
|
2024
Q3 | $64.7K | Hold |
18,472
| – | – | 0.08% | 61 |
|
|
2024
Q2 | $60.6K | Hold |
18,472
| – | – | 0.08% | 21 |
|
|
2024
Q1 | $136K | Hold |
18,472
| – | – | 0.2% | 21 |
|
|
2023
Q4 | $69.1K | Hold |
18,472
| – | – | 0.11% | 27 |
|
|
2023
Q3 | $39.2K | Hold |
18,472
| – | – | 0.07% | 30 |
|
|
2023
Q2 | $87.9K | Hold |
18,472
| – | – | 0.17% | 27 |
|
|
2023
Q1 | $105K | Sell |
18,472
-13,782
| -43% | -$78.6K | 0.19% | 23 |
|
|
2022
Q4 | $325K | Buy |
32,254
+18,089
| +128% | +$183K | 0.67% | 28 |
|
|
2022
Q3 | $318K | Sell |
14,165
-724
| -5% | -$16.3K | 0.65% | 37 |
|
|
2022
Q2 | $371K | Buy |
14,889
+2,794
| +23% | +$69.6K | 0.4% | 65 |
|
|
2022
Q1 | $469K | Sell |
12,095
-4,971
| -29% | -$193K | 0.35% | 59 |
|
|
2021
Q4 | $999K | Sell |
17,066
-2,844
| -14% | -$166K | 0.99% | 31 |
|
|
2021
Q3 | $1.18M | Buy |
+19,910
| New | +$1.18M | 0.88% | 31 |
|
|
2021
Q1 | – | Sell |
-2,752
| Closed | -$250K | – | 190 |
|
|
2020
Q4 | $250K | Buy |
+2,752
| New | +$250K | 0.15% | 124 |
|